Type B3 Thymoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) (NCT03449173) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-03-02 |
Track Type B3 Thymoma automatically
Every clearance here is in the API, with alerts when new ones post.